medRxiv preprint

Pregnancy outcomes in Autoimmune rheumatic disease Associated secondary Anti phospholipid syndrome vs primary Antiphospholipid syndrome: A retrospective observational study from Quaternery centre Apollo main hospital chennai

BackgroundAntiphospholipid syndrome (APS) complicating pregnancy carries significant obstetric morbidity. Secondary APS, arising in the context of systemic autoimmune disease, may confer worse outcomes than primary APS due to additional inflammatory and immunological mechanisms. This study aimed to compare pregnancy outcomes between autoimmune rheumatic disease-associated secondary APS and primary APS managed at a quaternary care hospital in Chennai. MethodsA retrospective observational study analysed 82 pregnancies (secondary APS n=46; primary APS n=36) managed between January 2025 and March 2026. Outcomes including live birth rate, miscarriage, fetal death, preterm birth, pre-eclampsia, an

rheumatology